A case-control study of phosphodiesterase-5 inhibitor use and Alzheimer’s disease and related dementias among male and female patients aged 65 years and older supporting the need for a phase III clinical trial

Open Access

Peer-reviewed

Research Article

About the Authors

David S. Henry

Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Software, Writing – original draft, Writing – review & editing

Affiliation Baptist Health Center for Clinical Research, Little Rock, Arkansas, United States of America

Richard G. Pellegrino

Roles Conceptualization, Formal analysis, Investigation, Methodology, Project administration, Supervision, Writing – review & editing

Affiliation Baptist Health Center for Clinical Research, Little Rock, Arkansas, United States of America

The authors have declared that no competing interest exists.

Alzheimer's disease
Is the Subject Area "Alzheimer's disease" applicable to this article?

Thanks for your feedback.
Erectile dysfunction
Is the Subject Area "Erectile dysfunction" applicable to this article?

Thanks for your feedback.
Receptor antagonist therapy
Is the Subject Area "Receptor antagonist therapy" applicable to this article?

Thanks for your feedback.
Pulmonary hypertension
Is the Subject Area "Pulmonary hypertension" applicable to this article?

Thanks for your feedback.
Medical risk factors
Is the Subject Area "Medical risk factors" applicable to this article?

Thanks for your feedback.
Dementia
Is the Subject Area "Dementia" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Electronic medical records
Is the Subject Area "Electronic medical records" applicable to this article?

Thanks for your feedback.